Displaying 1 to 5 of 5 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Initial investment. Round participant. Active |
|
|
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. |
United States | 4 Mar 2021 | Series A Initial investment. Round participant. Active |
|
|
Poseida Therapeutics Inc |
United States | 22 Apr 2019 | Series C Round participant. Active |
|
|
|
Poseida Therapeutics Inc |
United States | 3 Apr 2018 | Series B Round participant. Active |
|
|
Tricida Inc |
United Kingdom | 15 Jul 2016 | Series C Led the investment round. Active |